Cardiovascular Systems CEO Scott Ward's 2022 pay rises 5% to $4.3M
Cardiovascular Systems reports 2022 executive compensation
By ExecPay News
Published: September 28, 2022
Cardiovascular Systems reported fiscal year 2022 executive compensation information on September 28, 2022.
In 2022, seven executives at Cardiovascular Systems received on average a compensation package of $1.8M, a 2% decrease compared to previous year.
Average pay of disclosed executives at Cardiovascular Systems
Scott R. Ward, Chief Executive Officer, received $4.3M in total, which increased by 5% compared to 2021. 75% of Ward's compensation, or $3.3M, was in stock awards. Ward also received $337K in non-equity incentive plan, $699K in salary, as well as $32K in other compensation.
For fiscal year 2022, the median employee pay was $141,945 at Cardiovascular Systems. Therefore, the ratio of Scott R. Ward's pay to the median employee pay was 31 to one.
Rhonda J. Robb, Chief Operating Officer, received a compensation package of $2.9M, which increased by 59% compared to previous year. 39% of the compensation package, or $1.1M, was in other compensation.
Jeffrey S. Points, Chief Financial Officer, earned $1.3M in 2022, a 3% increase compared to previous year.
Ryan D. Egeland, Chief Medical Officer, received $1.2M in 2022, which increases by 33% compared to 2021.
Alexander Rosenstein, General Counsel, earned $1.1M in 2022, a 4% increase compared to previous year.
Sandra Sedo, Chief Compliance Officer, received $943K in 2022.
John M. Hastings, Executive Vice President of Operations and Technology, earned $888K in 2022.
Cardiovascular Systems' fiscal year ends on June 30.
Related executives
Scott Ward
Cardiovascular Systems
Chief Executive Officer
Jeffrey Points
Cardiovascular Systems
Chief Financial Officer
Rhonda Robb
Cardiovascular Systems
Chief Operating Officer
Alexander Rosenstein
Cardiovascular Systems
General Counsel
Ryan Egeland
Cardiovascular Systems
Chief Medical Officer
Sandra Sedo
Cardiovascular Systems
Chief Compliance Officer
John Hastings
Cardiovascular Systems
Executive Vice President of Operations and Technology
You may also like
Source: SEC filing on September 28, 2022.